The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

16.74

-0.25

(-1.47%)

At close: 04:00PM EDT

16.61

-0.13

(-0.78%)

Pre-market:

07:00AM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	19	19	20	20
Avg. Estimate	0.05	0.19	0.64	1.26
Low estimate	-0.08	0.11	0.3	0.79
High estimate	0.17	0.27	0.97	2.16
Year ago EPS	-0.27	0.01	-0.37	0.64

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	18	18	20	20
Avg. Estimate	208.36M	241.81M	967.32M	1.09B
Low estimate	201.3M	235.9M	940.7M	993.2M
High estimate	223.7M	253M	983.8M	1.2B
Year ago sales	118.46M	157.81M	726.44M	967.32M
Sales growth (year/est)	75.90%	53.20%	33.20%	13.10%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.21	-0.08	-0.43	0.3
Actual EPS	-0.27	0.01	-0.4	0.28
Difference	-0.06	0.09	0.03	-0.02
Surprise %	-28.60%	112.50%	7.00%	-6.70%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	0.05	0.19	0.64	1.26
7 days ago	0.05	0.2	0.66	1.28
30 days ago	0.06	0.2	0.67	1.28
60 days ago	0.2	0.33	1.04	1.8
90 days ago	0.21	0.34	1	1.78

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	1	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	1	1	1	1

Growth estimates	ACAD	Industry	Sector(s)	S&P 500
Current qtr.	118.50%	N/A	N/A	N/A
Next qtr.	1,800.00%	N/A	N/A	N/A
Current year	273.00%	N/A	N/A	N/A
Next year	96.90%	N/A	N/A	N/A
Next 5 years (per annum)	-357.00%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A